Chief Executive Officer and Managing Director of Ranbaxy Malvinder Singh answers a question during a press conference in New Delhi on June 11, 2008. India`s top generics firm Ranbaxy announced Wednesday settlement of a legal fight with Pfizer giving the US drug giant longer patent protection for the blockbuster anti-cholesterol medicine Lipitor. (AFP Photo)




